Skip to main content
Taylor & Francis Open Select logoLink to Taylor & Francis Open Select
. 2016 Oct 11;23(sup1):3–7. doi: 10.1080/09286586.2016.1230223

Assessment of Trachoma in Cambodia: Trachoma Is Not a Public Health Problem

Ngy Meng a,, Do Seiha a, Pok Thorn b, Rebecca Willis c, Rebecca M Flueckiger d, Michael Dejene e, Susan Lewallen f, Paul Courtright f, Anthony W Solomon d,*
PMCID: PMC5706964  PMID: 27726472

ABSTRACT

Purpose: To determine whether trachoma is a public health problem requiring intervention in Cambodia.

Methods: Based on historical evidence and reports, 14 evaluation units (EUs) in Cambodia, judged to be most likely to harbor trachoma, were selected. The Global Trachoma Mapping Project methodology was used to carry out rigorous surveys to determine the prevalence of trachomatous inflammation–follicular (TF) and trichiasis in each EU.

Results: The EU-level prevalence of TF among 25,801 1–9-year-old children examined ranged from 0% to 0.2%. Among the 24,502 adults aged 15+ years examined, trichiasis was found in 59 people. Age- and sex-adjusted prevalences of trichiasis in all ages in the EUs studied ranged from 0% to 0.14%; five EUs had a prevalence of trichiasis ≥0.1%.

Conclusions: There appears to be no need nor justification at this time for implementing public health measures to control trachoma in Cambodia.

KEYWORDS: Cambodia, eye health, Global Trachoma Mapping Project, trachoma, trichiasis

Introduction

Trachoma is a neglected tropical disease, and an important infectious cause of blindness. 1 Blindness from trachoma is difficult to cure, but possible to prevent, and the SAFE strategy (Surgery for trichiasis, Antibiotics to treat C. trachomatis infection, Facial cleanliness and environmental improvement to limit transmission) is widely accepted as the method to do this. 2 Cambodia is located on the Indochina Peninsula, surrounded by Thailand, Laos, Vietnam and the Gulf of Thailand; the estimated total national population was 13.4 million in the 2008 census. 3 About 80% of the population live in rural areas, with the overall population density estimated to be 75 people/km 2 . Trachoma has been recognized in Cambodia and documented in three peer reviewed publications in the 1990s. 4 6

In 2000, a series of trachoma rapid assessments (TRAs) 7 was conducted in Prey Veng, Svay Rieng and Takeo provinces. 8 On the basis of these assessments, some trachoma control activities including surgery provision, educational posters and leaflets, and distribution of tetracycline eye ointment at the health center and health post level were carried out for a short time when funding was available.

In 2004, the National Programme for Eye Health undertook a second TRA round in 80 villages of the provinces of Battambang, Kampong Chhnang, and Phnom Penh. These showed trachoma inflammation–follicular (TF) 9 in up to 15% of children examined in some villages. 10

Following review of the evidence described above and consultancies with the National Programme for Eye Health, the World Health Organization (WHO) Western Pacific Regional Office, the WHO Country Office, and non-governmental development organizations with an interest in trachoma control in Cambodia, it was concluded in 2013 that there was some trachoma in Cambodia but it was not possible to say whether or not the prevalence was currently of public health significance.

Therefore, a decision was made to conduct a study of sufficient rigor to determine if any provinces had a prevalence of TF in 1–9-year-old children of 10% or more, or a prevalence of trichiasis in all ages of 0.1% or more, so that Cambodia could implement SAFE if necessary or, alternatively, provide the evidence needed to document elimination of the disease as a public health problem. 11 The Global Trachoma Mapping Project (GTMP) methodology 12 was selected for the survey.

Materials and methods

GTMP methods require that the survey area be divided into evaluation units (EUs). The EUs determined for the mapping were based on the 24 provinces, however because of the wide range in number of people resident within the provinces, (40,208 in Kep to 2,234,566 in Phnom Penh) some were split and others combined for more uniformity in population size. Kep (population 40,208) and Kampot (population 585,110) were combined into one evaluation unit; Pailin (population 70,483) and Battambang (population 1,038,789) were combined and then the resulting area divided in half into two evaluation units. Mondulkiri has a relatively small population (60,811), but a large area, so it was surveyed as a single evaluation unit. Because Kampong Chhnang and Kandal each have populations greater than 1 million, each was divided into two evaluation units of approximately equal size. A total of 24 EUs were therefore defined, as shown in Table 1. Approval for the study was provided by the local Cambodian Ministry of Health, through the lead author, and the study adhered to the tenets of the Declaration of Helsinki.

Table 1.

Evaluation units defined for Cambodia, Global Trachoma Mapping Project, 2014–2015.

Province Evaluation unit Population, n
Battambang Banteay Meanchay 678,033
Battambang Battambang Aa 558,640
Battambang Battambang/Pailina 550,632
Kampong Cham Kampong Cham A 861,320
Kampong Cham Kampong Cham B 989,420
Kandal Kampong Chnanga 472,616
Kandal Kampong Speuna 716,517
Kampong Cham Kampong Thom 708,398
Kompot Kampot 585,110
Kompot Kep (to combine with Kampot) 40,208
Kandal Kandal Aa 638,321
Kandal Kandal Ba 643,631
Kompot Koh Kong 139,722
Stueng Treng Kratiea 318,523
Stueng Treng Mondul Kiria 60,811
Battambang Odam Meanchay 185,443
Kompot Preah Sihanouk 199,902
Stueng Treng Preah Viheara 170,852
Battambang Pursat 397,107
Kampong Cham Prey Veng Aa 538,014
Kampong Cham Prey Veng Ba 596,170
Stueng Treng Ratanakiria 149,997
Battambang Siem Reap 896,309
Stueng Treng Stung Treng 111,734
Kampong Cham Svay Ringa 571,491
Kompot Takeoa 964,471

aSelected for survey.

The 14 EUs believed most likely to have significant trachoma were selected for investigation. These EUs comprised areas from the 2000 and 2004 TRAs (6 EUs), areas with relatively high population densities, areas based on knowledge of cases of trichiasis presenting to the hospitals serving those provinces and perception of poor access to water and sanitation (6 EUs), and two EUs (Ratanak Kiri and Mondul Kiri) in very mountainous, isolated, poorly developed areas with minority populations, similar to areas in neighboring countries that have reported trachoma. Surveys were planned in these 14 EUs.

The sample size calculation for each survey was based on TF prevalence and used the single population proportion for precision formula. 13 To estimate a true TF prevalence of 10% in 1–9-year-olds with an absolute precision of 3%, assuming a cluster survey design effect of 2.65 and inflation by a factor of 1.2 to account for non-response, each survey required sufficient households to yield 1222 children. 12 In rural Cambodia, the mean household size is 4.6 people of whom 23% were expected to be aged 1–9 years (a mean of 1.1 children aged 1–9 years/household). Therefore, 1222/1.1=1155 households were required per survey. Assuming that a team could complete 30 households per day, this required 39 clusters per survey.

For each survey, two-stage cluster sampling was used. In the first stage, 39 clusters within each EU were selected from a census list of all villages, using a probability proportional to size, systematic sampling method. In the second stage, at the village, a systematic sample of 30 households was selected from a list of all households with children aged 1–9 years. It was necessary to select from a list of households with appropriately aged children because during the pilot phase it became clear that up to 2/3 households did not have any resident 1–9-year-old children, and much time was wasted going house to house to learn this.

In selected households, the standard GTMP protocol 12 was observed, with one GTMP-certified grader, one GTMP-certified recorder, and a local guide from the health center. GPS data were collected at each household.

Informed verbal consent for examination was obtained from all participants, or (for those younger than 15 years) their parent or legal guardian. Examination of each consenting individual for the signs trichiasis, TF and trachomatous inflammation-intense (TI) was conducted using binocular magnifying loupes and sunlight or a torch for illumination. The presence of trichiasis was recorded as “trachomatous trichiasis” (TT), implying causation by trachoma, although the presence or absence of trachomatous scarring was not recorded. Consent or refusal was formally noted by the data recorder for each household resident. Teams were trained following the GTMP training system. 14 In order to ensure that there would be enough children with TF for adequate training, grader candidates travelled to Ethiopia in May 2014 to undergo the standard GTMP grader training and certification. Graders who qualified then joined the recorders in Battambang Province, Cambodia, for additional team training in the survey methodology and field procedures.

All data, including consent, were captured electronically, using the purpose-built Open Data Kit-based Android smartphone application developed by the GTMP. 15 The data tool was in English. Once approved by a national official, data were sent and stored in the dedicated cloud-based, high security GTMP server. Data were cleaned and analyzed to provide a report of the prevalence of TF and TT in the sample population for each EU; the methodology for calculating prevalences involved age- and sex-adjustment, as previously described. 12 Confidence intervals were determined by bootstrap. 12

Following completion of the population-based prevalence surveys described above, it was noted that of the villages in which the 2004 TRAs had been undertaken, none of the three with the highest TF prevalences had been selected for sampling. Additional fieldwork was therefore undertaken in and around these villages. These potential hot-spots, grouped around the index villages, were as follows:

  1. Roung Ampil Village, Romeas Commune, Battambang Province; 13% of examined children had TF in the 2004 TRA. Its closest neighboring village, Khos Ream was also included.

  2. Chroark Thnoat Village, Chhaen Laeung Commune, Kampong Chhnang Province; 15% of examined children had TF in the 2004 TRA. Neighboring villages Krang Samrong and Anlong Pring were also included.

  3. Damnak Key Village, Choeung Kriev Commune, Kampong Chhnang Province; 14% of examined children had TF in the 2004 TRA. Neighboring villages Souphi and Trapeng Popel were also included.

In each of these villages, all children aged 1–9 years were requested to come to a central location for examination by GTMP-certified graders, following an advance visit by a member of the survey team to explain the purpose and methods of the investigation. Teams were assisted by the head of the respective village.

Results

Surveys in 14 EUs were carried out from June 2014 through March 2015 by eight teams. Results for TF and TT are shown in Table 2. In total, 25,801 children aged 1–9 years, and 24,502 adults over 15 years were examined, with participation rates of 97.3% and 59.6%, respectively. The prevalence of TF in 1–9-year-olds varied from 0% to 0.2%, well under the threshold of 5% in each EU. The estimated prevalence of trichiasis in all ages ranged from 0% to 0.14%; five EUs had a prevalence of trichiasis between 0.1% and 0.14%. TI was not found in 11 EUs; the age-adjusted prevalence of TI in Mondul Kiri, Preyveng A, and Takeo was 0.03%, 0.16% and 0.05%, respectively.

Table 2.

Prevalence of trachomatous inflammation–follicular (TF) and trichiasis, in 14 evaluation units of Cambodia, Global Trachoma Mapping Project, 2014–2015.

Province Evaluation unit Children (1–9 years) enumerated, n Children (1–9 years) examined, n (%) Children with TF, n Age-sex- adjusted TF prevalence in children, % (95% CI) Adults (15+ years) enumerated, n Adults examined (15+ years), n (%) Adults with trichiasis, n Age-sex-cluster size-adjusted trichiasis prevalence in adults, %(95% CI) Trichiasis prevalence in whole populationa, %
Battambang Battambang A 2014 1967 (97.7) 2 0.10 (0.00–0.24) 2845 1900 (66.8) 7 0.17 (0.04–0.34) 0.11
Battambang Battambang/Pailin 1932 1883 (97.5) 1 0.09 (0.00–0.27) 2787 1808 (64.9) 4 0.22 (0.02–0.51) 0.14
Kandal Kampong Chnang 1955 1905 (97.4) 1 0.03 (0.00–0.10) 3050 1797 (58.9) 3 0.07 (0.00–0.17) 0.04
Kandal Kampong Speun 1807 1769 (97.9) 1 0.10 (0.00–0.29) 2763 1527 (55.3) 12 0.18 (0.05–0.34) 0.12
Kandal Kandal A 1832 1801 (98.3) 1 0.09 (0.00–0.27) 2861 1609 (56.2) 3 0.06 (0.00–0.12) 0.04
Kandal Kandal B 1842 1787 (97.0) 0 0.00 (0.00–0.00) 3049 1795 (58.9) 8 0.17 (0.02–0.39) 0.12
Stueng Treng Kratie 1932 1871 (96.8) 0 0.00 (0.00–0.00) 3052 1902 (62.3) 3 0.04 (0.00–0.08) 0.03
Stueng Treng Mondul Kiri 2104 2038 (96.9) 0 0.00 (0.00–0.00) 2793 1767 (63.3) 2 0.06 (0.00–0.17) 0.04
Stueng Treng Preah Vihear 1879 1803 (95.9) 2 0.17 (0.00–0.35) 2805 1686 (60.1) 5 0.10 (0.00–0.23) 0.06
Kampong Cham Prey Veng A 1768 1702 (96.3) 3 0.20 (0.00–0.46) 3311 1715 (51.8) 2 0.04 (0.00–0.11) 0.03
Kampong Cham Prey Veng B 1813 1740 (95.9) 0 0.00 (0.00–0.00) 2949 1707 (57.9) 4 0.06 (0.00–0.14) 0.04
Stueng Treng Ratanakiri 2161 2133 (98.7) 1 0.03 (0.00–0.08) 2770 1735 (62.6) 0 0.00 (0.00–0.00) 0.00
Kampong Cham Svay Ring 1707 1666 (97.6) 0 0.00 (0.00–0.00) 2937 1697 (57.8) 0 0.00 (0.00–0.00) 0.00
Kompot Takeo 1782 1736 (97.4) 0 0.00 (0.00–0.00) 3108 1857 (59.7) 6 0.15 (0.03–0.31) 0.10

aAssumed 0.66% is 15+ years.

CI, confidence interval.

Discussion

The results of the rigorously executed national trachoma survey in Cambodia, using GTMP methods, clearly indicate that active trachoma, based on prevalence of TF, is not a public health problem in Cambodia. Additional surveys in village groups with historical data suggesting high TF burdens provide extra weight to this assertion. This is despite the fact that minimal activities aimed at trachoma elimination have been undertaken in the country over the past decade. On the other hand, general socioeconomic conditions have improved 16 and the birth rate has decreased, 16 resulting in far fewer children per household than in the past, and it is likely that these factors have contributed to the current situation.

The age- and sex-adjusted all-age prevalence of trichiasis was 0.1% or slightly higher in five surveyed EUs. Since carrying out the survey, there has been a shift to using TT prevalence in over 15-year-olds to gauge success against elimination thresholds, with <0.2% in this age group being equivalent to <0.1% in the all-ages population; in Cambodia this would result in only one district (Battambang/Pailin) being above the WHO elimination threshold. Although the WHO has set a TT prevalence target as part of the definition of elimination of trachoma as a public health problem, it is well recognized 12 that the sample size for measuring TT prevalence in the GTMP is too small to demonstrate this prevalence with precision. Indeed, the confidence intervals of TT prevalence in adults overlapped 0.2% in six EUs (Table 2). However, since no examination was performed for trachomatous scarring, it is not even certain that the cases of trichiasis that we identified were due to trachoma. In any event, facilities with capacity to provide surgery for trichiasis exist in all six of these EUs.

In view of these findings, we conclude that there is no need or justification for starting special outreach programs to identify people with TT, nor for implementing the SAFE strategy in Cambodia. Routine surveillance, including reporting of cases of TF or TT within each province, is recommended.

Appendix

The Global Trachoma Mapping Project Investigators are: Trainers for Cambodia Graders (Shashamene, Ethiopia, 2014): Tezera Kifle Desta, Tesfaye Haileselassie, Amir B. Kello; Pan-Project: Agatha Aboe (1,11), Liknaw Adamu (4), Wondu Alemayehu (4,5), Menbere Alemu (4), Neal D. E. Alexander (9), Berhanu Bero (4), Simon J. Brooker (1,6), Simon Bush (7,8), Brian K. Chu (2,9), Paul Courtright (1,3,4,7,11), Michael Dejene (3), Paul M. Emerson (1,6,7), Rebecca M. Flueckiger (2), Allen Foster (1,7), Solomon Gadisa (4), Katherine Gass (6,9), Teshome Gebre (4), Zelalem Habtamu (4), Danny Haddad (1,6,7,8), Erik Harvey (1,6,10), Dominic Haslam (8), Khumbo Kalua (5), Amir B. Kello (4,5), Jonathan D. King (6,10,11), Richard Le Mesurier (4,7), Susan Lewallen (4,11), Thomas M. Lietman (10), Chad MacArthur (6,11), Colin Macleod (3,9), Silvio P. Mariotti (7,11), Anna Massey (8), Els Mathieu (6,11), Siobhain McCullagh (8), Addis Mekasha (4), Tom Millar (4,8), Caleb Mpyet (3,5), Beatriz Muñoz (6,9), Jeremiah Ngondi (1,3,6,11), Stephanie Ogden (6), Alex Pavluck (2,4,10), Joseph Pearce (10), Serge Resnikoff (1), Virginia Sarah (4), Boubacar Sarr (5), Alemayehu Sisay (4), Jennifer L. Smith (11), Anthony W. Solomon (1,2,3,4,5,6,7,8,9,10,11), Jo Thomson (4); Sheila K. West (1,10,11), Rebecca Willis (2,9).

Key: (1) Advisory Committee, (2) Information Technology, Geographical Information Systems, and Data Processing, (3) Epidemiological Support, (4) Ethiopia Pilot Team, (5) Master Grader Trainers, (6) Methodologies Working Group, (7) Prioritisation Working Group, (8) Proposal Development, Finances and Logistics, (9) Statistics and Data Analysis, (10) Tools Working Group, (11) Training Working Group.

Funding Statement

This study was generously supported by the American people through the United States Agency for International Development (USAID), which funded the costs of the fieldwork described herein via its END in Asia grant to FHI 360. Core support to the Global Trachoma Mapping Project was provided by a grant from the United Kingdom’s Department for International Development (DFID)(ARIES: 203145) to Sightsavers. A committee established in March 2012 to examine issues surrounding completion of global trachoma mapping was initially supported by a grant from Pfizer to the International Trachoma Initiative. AWS was a Wellcome Trust Intermediate Clinical Fellow (098521) at the London School of Hygiene & Tropical Medicine. None of the funders had any role in project design, in project implementation or analysis or interpretation of data, in the decisions on where, how or when to publish in the peer reviewed press, or in preparation of this manuscript. The contents of this manuscript are the responsibility of the Ministry of Health, Cambodia and do not necessarily reflect the views of USAID or the Governments of the United Kingdom or United States.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the writing and content of this article.

Funding

This study was generously supported by the American people through the United States Agency for International Development (USAID), which funded the costs of the fieldwork described herein via its END in Asia grant to FHI 360. Core support to the Global Trachoma Mapping Project was provided by a grant from the United Kingdom’s Department for International Development (DFID)(ARIES: 203145) to Sightsavers. A committee established in March 2012 to examine issues surrounding completion of global trachoma mapping was initially supported by a grant from Pfizer to the International Trachoma Initiative. AWS was a Wellcome Trust Intermediate Clinical Fellow (098521) at the London School of Hygiene & Tropical Medicine. None of the funders had any role in project design, in project implementation or analysis or interpretation of data, in the decisions on where, how or when to publish in the peer reviewed press, or in preparation of this manuscript. The contents of this manuscript are the responsibility of the Ministry of Health, Cambodia and do not necessarily reflect the views of USAID or the Governments of the United Kingdom or United States.

References

  • 1. Solomon AW, Zondervan M, Kuper H, et al. Trachoma control: a guide for program managers. Geneva: World Health Organization, 2006. [Google Scholar]
  • 2. World Health Organization. International alliance formed for elimination of trachoma [press release 26 November 1996, WHO/82]. 1996. Available at: http://www.who.int/archives/inf-pr-1996/pr96-82.html
  • 3. National Institute of Statistics. General population census of Cambodia 2008: Report on post enumeration survey. Phnom Penh: Kingdom of Cambodia Ministry of Planning; 2009. [Google Scholar]
  • 4. Jackson H, Foster A.. Causes of blindness in northwest Cambodia. Ophthalmic Epidemiol 1997;4:27–32. [DOI] [PubMed] [Google Scholar]
  • 5. Thomson I. A clinic based survey of blindness and eye disease in Cambodia. Br J Ophthalmol 1997;81:578–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Rutzen AR, Ellish NJ, Schwab L, et al. Blindness and eye disease in Cambodia. Ophthalmic Epidemiol 2007;14:360–366. [DOI] [PubMed] [Google Scholar]
  • 7. Negrel AD, Taylor HR, West S.. Guidelines for the rapid assessment for blinding trachoma. Geneva: World Health Organization, 2001. [Google Scholar]
  • 8. Yutho U. Trachoma in Cambodia [Presentation at the 6th meeting of The WHO Alliance For the Global Elimination of Blinding Trachoma, 5 November 2001]. Geneva: Kingdom of Cambodia Ministry of Health, 2001. [Google Scholar]
  • 9. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477–483. [PMC free article] [PubMed] [Google Scholar]
  • 10. Seiha D, Leng TC. Assessment Trachoma Rapid. 2004. in Cambodia. [Presentation prepared for the 9th meeting of The WHO Alliance For the Global Elimination of Blinding Trachoma, Geneva, 21–23 March 2005]. Geneva: Kingdom of Cambodia Ministry of Health, 2004. [Google Scholar]
  • 11. World Health Organization Strategic and Technical Advisory Group on Neglected Tropical Diseases Technical consultation on trachoma surveillance. Geneva: World Health Organization, 2015. [Google Scholar]
  • 12. Solomon AW, Pavluck AL, Courtright P, et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol 2015;22:214–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kirkwood BR. Essentials of medical statistics. Oxford: Blackwell Science, 1988. [Google Scholar]
  • 14. Courtright P, Gass K, Lewallen S, et al. Global trachoma mapping project: training for mapping of trachoma (version 3) [Available at: http://www.trachomacoalition.org/resources/global-trachoma-mapping-project-training-mapping-trachoma]. London: International Coalition for Trachoma Control, 2015.
  • 15. Pavluck A, Chu B, Mann Flueckiger R, et al. Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based system. PLoS Negl Trop Dis 2014;8:e2654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. WHO, UNICEF, UNFPA, The World Bank, and United Nations Population Division Maternal Mortality Estimation Inter-Agency Group. Maternal Mortality Cambodia : 1990–2013. Available at: http://www.who.int/gho/maternal_health/countries/khm.pdf. 2013.

Articles from Ophthalmic Epidemiology are provided here courtesy of Taylor & Francis

RESOURCES